RELMADA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $208.3M | $44.4M |
| FY2022 | — | $140.4M | $5.4M |
| FY2023 | — | $85.4M | $4.1M |
| FY2024 | — | $35.5M | $3.9M |
| FY2025 | — | $86.5M | $3.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $208.3M | $44.4M |
| FY2022 | — | $140.4M | $5.4M |
| FY2023 | — | $85.4M | $4.1M |
| FY2024 | — | $35.5M | $3.9M |
| FY2025 | — | $86.5M | $3.5M |